ArticleThe pharmacogenomics journal2021

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.

Caterina Vivaldi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.